Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-Mutation
Ning Yang, Zhiya Fan, Shiyang Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115857-115857
Closed Access | Times Cited: 20

Showing 20 citing articles:

Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 18
Application and challenges of nitrogen heterocycles in PROTAC linker
Yang Li, Junfeng Qu, Lizhi Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116520-116520
Closed Access | Times Cited: 13
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Recent advances in targeted degradation in the RAS pathway
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
Miao Hao, Tian‐Xing Zhang, Dan Dong, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Targeting KRAS-G12C in Lung Cancer: The Emerging Role of PROTACs in Overcoming Resistance
Kumarappan Chidambaram, Arcot Rekha, Ahsas Goyal, et al.
Pathology - Research and Practice (2025), pp. 155954-155954
Closed Access
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 51-69
Closed Access | Times Cited: 4
Rational design of VHL-recruiting KRASG12C proteolysis-targeting chimeras based on molecular dynamics simulation
Shiyang Sun, Ning Yang, Yaqiu Mao, et al.
Chinese Chemical Letters (2025), pp. 110992-110992
Closed Access
Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy
Yue Shen, Jie-Qi Chen, Xiangping Li
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101374-101374
Open Access | Times Cited: 3
Covalent Proximity Inducers
Nir London
Chemical Reviews (2024)
Open Access | Times Cited: 2
Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
Bikash Adhikari, Katharina Schneider, Mathias Diebold, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
Bikash Adhikari, Katharina Schneider, Mathias Diebold, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
Bikash Adhikari, Katharina Schneider, Mathias Diebold, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
Bikash Adhikari, Katharina Schneider, Mathias Diebold, et al.
(2024)
Open Access
eLife assessment: Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
Agnieszka Chacińska
(2024)
Open Access
Reviewer #1 (Public Review): Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)

(2024)
Open Access
Reviewer #2 (Public Review): Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)

(2024)
Open Access
Covalency in PROTACs: Mechanisms and applications
Thomas Geiger, Radosław P. Nowak
Annual reports in medicinal chemistry (2024), pp. 39-61
Closed Access
Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
Bikash Adhikari, Katharina Schneider, Mathias Diebold, et al.
(2024)
Open Access
Page 1

Scroll to top